Sun Pharmaceutical Industries, India’s top drugmaker by revenue, reported a quarterly profit above analysts estimates on Wednesday, helped by strong demand for its drugs in the domestic market.The Mumbai-based firm’s consolidated net profit stood at 31.18 billion rupees ($354.7 m





